
PFRMAT AL
TARGET T0121
AUTHOR 4035-9795-7731 
METHOD bioinbgu consensus 
MODEL  5
PARENT 1bym_A
REMARK  bbb      b             bbbbbbbbbbb                
REMARK  FGIRPEDLYDAMFARVRVP.GENLVRAVVEIVENL...............
REMARK   |    |                     | | |                 
REMARK  LGVGNSDAAAPGTRVIDAATSMPRKVRIVQINEIFQVETDQFTQLLDADI
REMARK              hhhhh       bbbbbb        hhhhhhhhhh  
REMARK      bbbbbbb   bbbb   bbb          bbbbb
REMARK  ..GSERIVHLRVGGVTFV...GAFRSESRVREGVEVDVV
REMARK    |||     | |  |                       
REMARK  RVGSEVEIVDRDGHITLSHNGKDVELLDDLAHTIRIEEL
REMARK     bbbbbbbb  bbbbbbb bbb  hhhhhh  bbbbb
REMARK TARGET  FROM-TO   FOLD       FROM-TO  ALIG No.
REMARK TALIGN SEQ 0    47  65  1BYM - 0      8  26  1.0 1
I 286 E 137
F 287 L 138
G 288 G 139
I 289 V 140
R 290 G 141
P 291 N 142
E 292 S 143
D 293 D 144
L 294 A 145
Y 295 A 146
D 296 A 147
A 297 P 148
M 298 G 149
F 299 T 150
A 300 R 151
R 301 V 152
V 302 I 153
R 303 D 154
V 304 A 155
REMARK TALIGN SEQ 0    66  80  1BYM - 0     28  42  1.0 1
P 305 T 157
G 306 S 158
E 307 M 159
N 308 P 160
L 309 R 161
V 310 K 162
R 311 V 163
A 312 R 164
V 313 I 165
V 314 V 166
E 315 Q 167
I 316 I 168
V 317 N 169
E 318 E 170
N 319 I 171
REMARK TALIGN SEQ 0    81  96  1BYM - 0     60  75  1.0 1
L 320 V 189
G 321 G 190
S 322 S 191
E 323 E 192
R 324 V 193
I 325 E 194
V 326 I 195
H 327 V 196
L 328 D 197
R 329 R 198
V 330 D 199
G 331 G 200
G 332 H 201
V 333 I 202
T 334 T 203
F 335 L 204
REMARK TALIGN SEQ 0    97 114  1BYM - 0     79  96  1.0 1
V 336 G 208
G 337 K 209
A 338 D 210
F 339 V 211
R 340 E 212
S 341 L 213
E 342 L 214
S 343 D 215
R 344 D 216
V 345 L 217
R 346 A 218
E 347 H 219
G 348 T 220
V 349 I 221
E 350 R 222
V 351 I 223
D 352 E 224
V 353 E 225
TER
END

